BIOX — Bioceres Crop Solutions Income Statement
0.000.00%
Basic MaterialsAdventurousMid CapNeutral
- $849.16m
- $1.08bn
- $328.41m
- 88
- 42
- 61
- 68
Annual income statement for Bioceres Crop Solutions, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2018 June 30th | 2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 134 | 160 | 172 | 207 | 328 |
Cost of Revenue | |||||
Gross Profit | 56.4 | 73.4 | 78.8 | 88.1 | 120 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 118 | 128 | 133 | 168 | 289 |
Operating Profit | 15.7 | 32.1 | 39.1 | 38.4 | 39.9 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -25.2 | -9.37 | 6.44 | 10.5 | 14.1 |
Provision for Income Taxes | |||||
Net Income After Taxes | -14.3 | -16.4 | 4.24 | -3.82 | -3.91 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -11 | -18.4 | 3.36 | -6.87 | -7.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -11 | -18.4 | 3.36 | -6.87 | -7.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.393 | -0.609 | 0.079 | -0.222 | -0.268 |